TopNewsToday.org
»
»
»

Johnson & Johnson drug slows prostate cancer spread by 58 percent: trial

reuters.com (2 years and 1 month ago)

Jun 2, 2012

CHICAGO (Reuters) - A trial of Johnson & Johnson's prostate cancer pill, Zytiga, found that it slowed the spread of the disease by 58 percent in men who had stopped responding to hormonal drugs but not yet treated with chemotherapy, potentially offering new hope for patients who see their cancer return. full story

More news more news

Johnson & Johnson drug slows prostate cancer spread by 58 percent: trial

reuters.com (2 years and 1 month ago)

ASCO '12: J&J Scores Big With Prostate Cancer Pill

thestreet.com (2 years and 1 month ago)

Testing Recommendation May Kill You

yahoo.com (2 years and 1 month ago)

Johnson & Johnson Prostate Cancer Drug Impresses

forbes.com (2 years and 1 month ago)

Drug slows advanced prostate cancer: study

yahoo.com (2 years and 1 month ago)

Prostate cancer drug so effective trial stopped

sfgate.com (2 years and 1 month ago)

Study: Hormone pill slows prostate cancer's growth

ap.org (2 years and 1 month ago)

Study: Hormone pill slows prostate cancer's growth

yahoo.com (2 years and 1 month ago)

Study: Hormone pill slows prostate cancer's growth

foxnews.com (2 years and 1 month ago)

Bristol Drug Unlocks Immune System to Shrink Tumors

thestreet.com (2 years and 1 month ago)

More Health news »

Most read

Most popular

Follow us

Facebook
Twitter
Google+
RSS Feed
US | Sport | Business | Technology | Lifestyle | Entertainment | World | Search
Privacy Policy | About | Contacts
All news and photos belong to their authors.